Form 4 Filing for 10x Genomics, Inc. - Officer/Director Transaction

This filing details transactions made by Sergeov Serge, CEO of 10x Genomics, Inc. On May 22, 2026, 18,175 shares of Class A Common Stock were sold at a weighted average price of $24.44 to cover tax obligations related to restricted stock units. On May 26, 2026, an additional 10,718 shares were sold at a weighted average price of $24.71 under a Rule 10b5-1 trading plan. Following these transactions, the reporting owner directly holds 1,138,380 shares. Indirectly held shares through various trusts amount to 27, 213,250, and 71,644 shares, as detailed in footnotes.